文献速递精神分裂症与精神病性障碍

精神分裂症患者的潜在寿命损失年与预期寿命:系统综述与荟萃分析

Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis.
PubMed 文献 · Lancet Psychiatry · 2017-02-22

发表时间与偏倚风险对结果影响不大,结论认为精神分裂症对寿命损失和预期寿命的影响重大且未随时间减轻。

要点

  • 寿命损失和预期寿命的负面影响未随发表时间推移而减轻。

核心结论

  • 精神分裂症与显著的潜在寿命损失年和缩短的预期寿命相关,且该影响未随时间减轻,亟需制定和实施缩小死亡率差距的干预措施。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、PsycINFO、Embase、Cinahl和Web of Science中关于精神分裂症潜在寿命损失年和预期寿命的已发表研究。
  • 数据以加权平均值进行荟萃分析,并按性别、地理区域、发表时间和偏倚风险(Newcastle-Ottawa量表)进行亚组分析。

主要发现

  • 潜在寿命损失年最少见于亚洲研究,最大见于非洲;预期寿命最低见于亚洲和非洲。
  • 发表时间和偏倚风险对结果影响不大。

临床怎么用

  • 临床应关注精神分裂症患者显著增高的过早死亡风险,并将其作为综合管理的重要目标。
  • 针对男性患者可能需更加强调减少寿命损失的干预措施。
  • 亟需制定和实施旨在缩小精神分裂症患者死亡率差距的干预和倡议。

局限性

  • 纳入研究地理分布不均衡(欧洲7项、北美3项、非洲1项、亚洲1项、澳大利亚1项),南美无研究。
  • 部分分析基于加权平均值,原始研究间异质性未详细报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several studies and meta-analyses have shown that mortality in people with schizophrenia is higher than that in the general population but have used relative measures, such as standardised mortality ratios. We did a systematic review and meta-analysis to estimate years of potential life lost and life expectancy in schizophrenia, which are more direct, absolute measures of increased mortality. METHODS: We searched MEDLINE, PsycINFO, Embase, Cinahl, and Web of Science for published studies on years of potential life lost and life expectancy in schizophrenia. Data from individual studies were combined in meta-analyses as weighted averages. We did subgroup analyses for sex, geographical region, timing of publication, and risk of bias (estimated with the Newcastle-Ottawa Scale). FINDINGS: We identified 11 studies in 13 publications covering all inhabited continents except South America (Africa n=1, Asia n=1, Australia n=1, Europe n=7, and North America n=3) that involved up to 247 603 patients. Schizophrenia was associated with a weighted average of 14·5 years of potential life lost (95% CI 11·2-17·8), and was higher for men than women (15·9, 13·8-18·0 vs 13·6, 11·4-15·8). Loss was least in the Asian study and greatest in Africa. The overall weighted average life expectancy was 64·7 years (95% CI 61·1-71·3), and was lower for men than women (59·9 years, 95% CI 55·5-64·3 vs 67·6 years, 63·1-72·1). Life expectancy was lowest in Asia and Africa. Timing of publication and risk of bias had little effect on results. INTERPRETATION: The effects of schizophrenia on years potential life lost and life expectancy seem to be substantial and not to have lessened over time. Development and implementation of interventions and initiatives to reduce this mortality gap are urgently needed. FUNDING: None.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Hjorthøj C, Stürup AE, McGrath JJ, et al. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017. PMID: 28237639. doi:10.1016/S2215-0366(17)30078-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。